Trade Shows
Press Releases
Continuing Education
Demos

 

Press Releases

Cetacaine Liquid KitCetacaine® Topical Anesthetic Liquid Kit

Cetylite’s new Cetacaine® Topical Anesthetic Liquid Kit is now available. Cetacaine’s triple-active formula (Benzocaine 14.0%, Butamben 2.0%,Tetracaine Hydrochloride 2.0%) is well-suited for scaling and root planing, providing patients with effective, non-injectable, cost-effective anesthesia. Only $2 for a full mouth application, the included 14g bottle yields up to 34 full mouth applications. The new unique dispenser cap for Luer-lock syringes allows the clinician to use only what they need, not exceeding 0.4ml maximum dose. Cetacaine has onset within 30 seconds and duration typically lasts 30 - 60 minutes.

Cetacaine Topical Anesthetic Liquid Kit contains: 14g bottle of Cetacaine Topical Anesthetic Liquid with a new unique dispenser cap, 20 Vista™ 1.2mL Luer-lock syringes, and 20 Vista-Probe™ 27ga tips.

Rx only.

Important Safety Information
On rare occasions, methemoglobinemia has been reported in connection with the use of benzocaine-containing products. Care should be used not to exceed the maximum recommended dosage. If a patient becomes cyanotic, treat appropriately to counteract (such as with methylene blue, if medically indicated). The most common adverse reaction caused by local anesthetics is contact dermatitis characterized by erythema and pruritus that may progress to vesiculation and oozing. This occurs most commonly in patients following prolonged self-medication, which is contraindicated.

Cetacaine is not right for everyone, including those who are hypersensitive to any of its ingredients or are known to have cholinesterase deficiencies. Please see the brief summary of the Prescribing Information on page six.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Contraindications:
Active Ingredients: Benzocaine 14.0 %, Butamben 2.0 %, Tetracaine Hydrochloride 2.0 %

Hypersensitivity Reactions: Unpredictable adverse reactions (i.e. hypersensitivity, including anaphalaxis) are extremely rare. Localized allergic reactions may occur after prolonged or repeated use of any aminobenzoate anesthetic. The most common adverse reaction caused by local anesthetics is contact dermatitis characterized by erythema and pruritus that may progress to vesiculation and oozing. This occurs most commonly in patients following prolonged self-medication, which is contraindicated. If rash, urticaria, edema, or other manifestations of allergy develop during use, the drug should be discontinued. To minimize the possibility of a serious allergic reaction, Cetacaine preparations should not be applied for prolonged periods except under continual supervision. Dehydration of the epithelium or an escharotic effect may also result from prolonged contact.

Precaution: On rare occasions, methemoglobinemia has been reported in connection with the use of benzocaine-containing products. Care should be used not to exceed the maximum recommended dosage (see Dosage and Administration). If a patient becomes cyanotic, treat appropriately to counteract (such as with methylene blue, if medically indicated).

Use in Pregnancy: Safe use of Cetacaine has not been established with respect to possible adverse effects upon fetal development. Therefore, Cetacaine should not be used during early pregnancy, unless in the judgment of a physician, the potential benefits outweigh the unknown hazards.

Contraindications: Cetacaine is not suitable and should never be used for injection. Do not use in eyes. To avoid excessive systemic absorption, Cetacaine should not be applied to large areas of denuded or inflamed tissue. Cetacaine should not be administered to patients who are hypersensitive to any of its ingredients or to patients known to have cholinesterase deficiencies. Tolerance may vary with the status of the patient. Cetacaine should not be used under dentures or cotton rolls, as retention of the active ingredients under a denture or cotton roll could possibly cause an escharotic effect. Routine precaution for the use of any topical anesthetic should be observed when using Cetacaine.